Clinical trial

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

NCT00113308

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE3

Study timeline

Study start (unknown)2005-06-01Date precision: month

Registry last updated2017-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritis, Rheumatoidunresolved

Interventions

GW406381DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

Buenos AiresArgentina5 SeoulSouth Korea4 MoscowRussia4 ViennaAustria4 TorontoOntario, Canada3 BarcelonaSpain3 San DiegoCalifornia, United States3 Las VegasNevada, United States3 BudapestHungary3 LouisvilleKentucky, United States3 BucharestRomania3 SofiaBulgaria3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00113308 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.